Clinical trial · Observational
Hürthle Cell Carcinoma and Follicular Thyroid Carcinoma
Clinicopathological Characteristics of Hürthle Cell Carcinoma and Follicular Thyroid Carcinoma Without Completion Thyroidectomy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this retrospective study is to evaluate in patients with HCC and FTC who underwent lobectomy. The main questions it aims to answer are: * The necessity of completion thyroidectomy based on the clinicopathological characteristics * Prognosis Participants underwent thyroid lobectomy Researchers compared HCC and FTC groups to see the prognosis after lobectomy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Huerthle Cell Carcinoma | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (2)
- label
- FTC
- description
- Follicular thyroid carcinoma
- label
- HCC
- description
- Hurthle cell carcinoma
Primary outcomes (1)
- measure
- Disease-free survival (DFS)
- timeFrame
- From January 2000 to March 2023
- description
- a comparison of disease-free survival (DFS) between FTC and HCC groups
Secondary outcomes (1)
- measure
- TNM stage
- timeFrame
- From January 2000 to March 2023
- description
- a comparison of TNM stage between FTC and HCC groups
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Follicular thyroid carcinoma * Hurthle cell carcinoma * Lobectomy Exclusion Criteria: * Completion thyroidectomy * Total thyroidectomy
References
Publications (0)
Data not yet available